Mutual fund holdings in Mono Pharmacare Limited: who holds it and who bought and sold in Sep 2026, with its other institutional holdings, each beside the price.
₹9.65▲ +4.9%
NSE close, 4 Nov 2026 · 1-year range ₹7.60 – ₹70.00
Data as of10 sources, each card shows its own date
MF: Sep 2026 portfolios (monthly), 45 fund houses coveredShares outstanding: NSE equity list, 4 Nov 2026Delivery: NSE security-wise delivery, 4 Nov 2026 · 195 days collectedDeals: NSE deal files, 4 Nov 2026SLBM: NSE, 4 Nov 2026 · 56 days collectedMTF: NSE, 3 Nov 2026 · 55 days collectedFlags: NSE, 4 Nov 2026FPI: no shareholding pattern collected yetPledge: no shareholding pattern collected yetInsider: Trades dated 7 Aug 2026 to 4 Nov 2026 (disclosures collected since 3 May 2026)
MF holding, % of equity
None held
Sep 2026
FPI holding, % of equity
—
No shareholding pattern for Mono Pharmacare has been collected yet.
Fund houses holding
0
0 entered, 0 exited · Sep 2026
Promoter pledge
—
No shareholding pattern for Mono Pharmacare has been collected yet.
Delivery
100.0%▲ +10.1 pp
4 Nov 2026
MTF book
—
NSE listed no margin trading position for Mono Pharmacare on any of the 55 days collected, 14 Aug 2026 to 3 Nov 2026.
Mutual funds
i
What it is. Shares of this company held by mutual funds, taken from the portfolio each fund house publishes for every month end. Some index-only schemes publish only every quarter. "Houses" counts the fund houses holding it in an active scheme.
How to read it. "% of equity" is the shares funds hold divided by all the company's shares. A change between two months compares only the houses with a portfolio in both months. Share counts move when funds add to or cut a holding, or when a split or bonus is applied.
Does not show: Trades inside the month, or why a fund changed its holding.
AMC portfolios, Sep 2026 · 45 fund houses covered
No tracked fund house held MONOPHARMA in Sep 2026.
Price
NSE close by day · 29 Sep 2023 to 4 Nov 2026
₹9.65 NSE close, 4 Nov 2026
29 Sep 20234 Nov 2026
₹7.60 to ₹70.00, split or bonus adjusted. Since first held = the close at the end of the first month any tracked fund held it, to the latest close.
Delivery
Delivery
i
What it is. Of all shares traded in a day, the part that was settled by delivery: the buyer receives the shares in their demat account. NSE counts this per client, so the rest is shares a client bought and sold within the same day (intraday).
How to read it. NSE publishes the share for every stock every day. Stocks differ in how much they are traded within the day, so compare a stock with its own past rather than with another stock. A 5-day figure smooths out single-day noise.
Does not show: Who the buyers were, or whether they plan to keep the shares.
4 Nov 2026
Share of the day's traded volume taken into demat instead of squared off the same day. A higher share means more of the trading was buying to hold.
100.0%▲ +10.1 pp vs 20-day average
20-day average 89.9% · 100th percentile of 195 days collected
7 Sep 20264 Nov 2026
By month over 38 months (Sep 2023 to Oct 2026), 84.7% of shares traded were delivered; lowest month 67.9% (Oct 2023), highest 99.2% (Feb 2025).
Share of each session's traded shares taken into demat. High delivery on a falling price means holders took the shares, not just day traders.
97%97%85%73%
Nov 2025Jan 2026Mar 2026May 2026Jul 2026Sep 2026
Delivery
F&O and margin
Red flags
i
What it is. Exchange lists that restrict trading in a stock: the F&O ban (no fresh F&O positions), and the Additional and Graded Surveillance Measures (ASM and GSM), which tighten trading conditions with steps such as higher margins, narrower price bands and trade-for-trade settlement.
How to read it. The card shows whether the stock is on a list today, from the exchange's daily files.
Does not show: Anything about the company beyond being listed.
4 Nov 2026
The exchange's own lists: F&O ban and surveillance. They say the stock is on a list, not why it moved.
No F&O
Mono Pharmacare has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed Mono Pharmacare under no ASM or GSM stage on 4 Nov 2026. Pledge invocations are not available yet.
NSE, 4 Nov 2026
Nothing to show for Mono Pharmacare in the period checkedNamed FPIs at 1% or more: No shareholding pattern for Mono Pharmacare has been collected yet. · Promoter pledge: No shareholding pattern for Mono Pharmacare has been collected yet. · Bulk and block deals: No bulk or block deals in Mono Pharmacare from 7 Aug 2026 to 4 Nov 2026. · Insider and promoter: No insider or promoter trade in Mono Pharmacare dated 7 Aug 2026 to 4 Nov 2026 was disclosed. · MTF book: NSE listed no margin trading position for Mono Pharmacare on any of the 55 days collected, 14 Aug 2026 to 3 Nov 2026. · SLBM borrowing: NSE listed no securities-lending (SLB) open position for Mono Pharmacare on any of the 56 days collected, 14 Aug 2026 to 4 Nov 2026. No SLBM trades in Mono Pharmacare on 4 Nov 2026.
On NSE ↗
NSE's own public pages for MONOPHARMA; this site does not copy them
